Explore 3 Stock Ideas & Industry Insights Download Free Report

News

What Should Investors Expect When NEXGEL, Inc. (NASDAQ:NXGL) Reports Q3 2026 Results on November 16, 2026?

The second quarter net loss of USD 2.87 million included USD 756,554 of intangible amortization, USD 273,710 ofTransaction Costsand USD 144,495 tied to recalling all SilverSeal inventory from Amazon. Management said rollout moved more slowly than planned. Sequence deployed tissue processing specialists to the …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Edible Garden AG Incorporated (NASDAQ:EDBL) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for Edible Garden AG Incorporated (NASDAQ:EDBL)

Vinay Lochav | 13 November 2026

What Should Investors Expect When Onfolio Holdings, Inc. (NASDAQ:ONFO) Reports Q3 2026 Results on November 16, 2026?

Second quarterGross Profitwas USD 732,003 versus USD 1,938,277, and operating expenses fell 31% to USD 1.70 million. The operating loss was USD 965,508 and Adjusted EBITDA was a loss of USD 776,256. Management attributed the revenue drop to slower new sales at Eastern Standard …

Vinay Lochav | 13 November 2026

What Should Investors Expect When 22nd Century Group (NASDAQ:XXII) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for 22nd Century Group, Inc. (NASDAQ:XXII)

Vinay Lochav | 13 November 2026

What Should Investors Expect When Karyopharm Therapeutics (NASDAQ:KPTI) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

Vinay Lochav | 13 November 2026

What Should Investors Expect When Functional Brands (OTCQB:MEHA) Reports Q3 2026 Results on November 16, 2026?

In the quarter ended June 30, 2026, reported on August 17, 2026,Gross Profitrose to USD 1,120,341 from USD 968,095. The operating loss widened to USD 1,320,398 from USD 155,437 and the net loss to USD 2,630,548 from USD 226,056, or USD 0.06 per share …

Vinay Lochav | 13 November 2026

What Should Investors Expect When ProPhase Labs, Inc. (OTCQB:PRPH) Reports Q3 2026 Results on November 16, 2026?

The second quarter report, filed on August 19, 2026, showed net revenue of USD 1.01 million against USD 1.25 million a year earlier, driven by lower consumer supplement sales. Gross margin was 22.4% versus 58.9%, which the company tied to product mix. General and …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Direct Digital Holdings, Inc. (NASDAQ:DRCT) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for Direct Digital Holdings, Inc. (NASDAQ:DRCT)

Vinay Lochav | 13 November 2026

What Should Investors Expect When Sangamo Therapeutics, Inc. (OTCQB:SGMO) Reports Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for Sangamo Therapeutics, Inc. (OTCQB:SGMO)

Vinay Lochav | 13 November 2026

Top 5 Biopharma Stocks Reporting on November 16, 2026: Omeros (NASDAQ:OMER) Q2 Net Revenue USD 28.5 Million, Jade Biosciences (NASDAQ:JBIO) Q2 Net Loss USD 55.8 Million, MapLight (NASDAQ:MPLT) Q2 Net Loss USD 60.2 Million, Enanta (NASDAQ:ENTA) Q3 Revenue USD 14.4 Million, Fulcrum (NASDAQ:FULC) Cash USD 318.8 Million

Key Highlights28.5 is the USD million of net YARTEMLEARevenueOmeros Corporation (NASDAQ:OMER) reported for the second quarter of 2026, compared with USD 9.9 million in the first quarter, its first full launch quarter.461.2 is the USD million of cash, cash equivalents and investments Jade Biosciences, …

Vinay Lochav | 13 November 2026
Support

Hi! How can we help you today?

Loading…